Apollo Hospitals Q2 FY27 Results Nov 4: Can Revenue Cross Rs 7,400 Crore After 21% Q1 Jump?

Apollo Hospitals Q2 FY27 Scheduled for November 4

Apollo Hospitals Enterprise is preparing to announce its Q2 FY27 financial results on Wednesday, November 4, 2026. Investors will closely track the September-quarter performance to determine whether the healthcare major can maintain its strong earnings momentum.

The company has also scheduled its analyst and investor conference call for Thursday, November 5, at 3:00 PM IST.

With healthcare demand, hospital expansion and digital pharmacy operations attracting investor attention, the upcoming Apollo Hospitals Q2 results could become an important trigger for the stock.

The market will particularly watch whether revenue growth translates into stronger profitability and improved operating margins.

Track Live : Results Calendar — NSE & BSE

Apollo Hospitals Q2 FY27 results schedule

The board meeting date is supported by the company’s exchange filing information. The conference-call schedule is reported in the company’s investor-event disclosures.

Apollo Hospitals Q2 FY27 Revenue and EBITDA: What Is the Base to Beat?

Investors will compare the September-quarter performance with the corresponding quarter of the previous financial year.

Apollo Hospitals reported revenue of ₹6,304 crore and EBITDA of ₹941 crore in Q2 FY26, translating into an EBITDA margin of approximately 14.94%.

The latest available quarterly performance provides another important benchmark.

In Q1 FY27, Apollo Hospitals reported revenue of ₹7,043 crore, marking 21% year-on-year growth. EBITDA increased 28% to ₹1,092 crore.

The following figures will be important when the company announces its Q2 FY27 results:

The supplied information does not establish a verified analyst consensus for Q2 FY27. Therefore, investors should treat the projected revenue of approximately ₹7,488 crore as a market-tracking reference rather than a confirmed brokerage consensus.

Q1 FY27 performance: Latest quarterly benchmark

Apollo Hospitals delivered strong growth in the June 2026 quarter, providing a reference point for Q2 expectations.

Track Live : NSE Option Chain — Live  |  BSE Option Chain — Live Sensex & Bankex Options Data Today

Hospital Growth and Apollo HealthCo Breakeven Remain Key Triggers

Beyond consolidated revenue, investors will closely monitor Apollo Hospitals’ individual business segments.

The hospital business remains a major growth driver, supported by increasing demand for specialised healthcare services.

High-acuity specialties, including complex and advanced treatments, have been particularly important. The supplied operating data indicates 24% growth in these specialties, accounting for approximately 62% of inpatient revenue.

However, expansion costs could influence profitability.

Management had indicated that new hospital ramp-up losses could reach approximately ₹150 crore for FY27, with facilities in Bengaluru and Gurgaon gradually scaling up.

Investors will also monitor the anticipated ₹100 crore cost impact associated with regional supply-chain and inflationary pressures.

Another major development is Apollo HealthCo. Its online digital business was targeting breakeven around Q2 FY27 after reducing digital cash losses to approximately ₹10 crore in Q1 FY27.

The September-quarter results could provide important clues about whether this target remains achievable.

Track Live : Nifty Levels Today | Sensex Levels Today

Key factors that could influence Q2 FY27 results

New hospital expansion and profitability

Apollo is expanding its hospital network, but newly commissioned facilities could put pressure on near-term profitability.

The important question is whether existing hospitals can maintain healthy profitability while new facilities gradually increase occupancy and operational efficiency.

Here’s What Happened Today and Why Traders Reacted

The upcoming results have placed Apollo Hospitals shares on investors’ watchlists ahead of the November 4 announcement.

The key factors influencing trading sentiment include:

• Revenue growth: Whether quarterly revenue moves closer to the ₹7,488 crore tracking benchmark.

• EBITDA margins: Whether operating profitability improves from the previous year’s 14.94% margin.

• Hospital expansion: Whether new facilities are scaling up without significantly increasing losses.

• Digital business: Whether Apollo HealthCo moves closer to its targeted breakeven.

• Management guidance: Whether the hospital revenue growth outlook of approximately 20% is maintained.

These developments could influence short-term trading activity and institutional investor expectations.

Read More : Indian Stock Market Rise: Why Foreign Investors Are Back With $2.28 Billion

What Impact Could Apollo Hospitals Q2 Results Have on Investors?

The Apollo Hospitals Q2 FY27 results could determine the stock’s near-term direction.

Better-than-expected revenue growth, improving EBITDA margins and progress towards HealthCo breakeven could support positive investor sentiment.

However, higher expansion costs, inflationary pressures or weaker-than-expected margins could create selling pressure.

Long-term investors should focus on hospital occupancy, profitability, new-bed utilisation and digital business performance rather than revenue growth alone.

One important point is the profit discrepancy appearing in different market reports. Figures of ₹477.2 crore and ₹581 crore, as well as ₹494 crore and ₹610 crore, have been circulated. Investors should verify whether these represent standalone or consolidated results and reported versus adjusted profit before comparing them.

What investors should watch on November 4

These are monitoring benchmarks, not guaranteed share-price triggers.